Literature DB >> 21958793

Vascularized atrial tissue patch cardiomyoplasty with omentopexy improves cardiac performance after myocardial infarction.

Changwei Zhang1, Jianfeng Hou, Shuai Zheng, Zhe Zheng, Shengshou Hu.   

Abstract

BACKGROUND: The tissue-engineered cardiac patch can alleviate ventricular remodeling and improve functional recovery in experimental myocardial infarction. However, the size of the engineered patch is limited due to insufficient vascularization. This study evaluated the effects of autologous atrial tissue patch cardiomyoplasty and omentopexy in rats with myocardial infarction.
METHODS: Myocardial infarction was induced by left coronary artery ligation in Sprague-Dawley rats. Three weeks later, either a patch of left atrium (A group) or omentum (O group) or both (OA group) were placed over the infarct zone. The atrial tissue patch was harvested from the autologous left atrial appendage along its long axis. The rats in the Control group received rethoracotomy only. After 4 weeks, the survival of the transplanted atrial tissue patch, ventricular remodeling, and cardiac performance were examined.
RESULTS: After 4 weeks, surviving myocardium was only detected in the OA group, as indicated by immunolabeling of cardiac troponin-I. Compared with the Control group, only animals in the OA group showed improved heart function assessed by left ventricular ejection fraction (57.9% ± 5.8% vs 47.5% ± 4.5%, p < 0.05) and left ventricular fractional shortening (25.2% ± 3.6% vs 20.7% ± 2.0%, p < 0.05). The histologic analysis demonstrated increased scar thickness in the OA group. This was accompanied by increased angiogenesis of the border zone but decreased expression and activity of matrix metalloproteinase and endothelin-1 levels.
CONCLUSIONS: The omentopexy supported the survival of the autologous atrial tissue patch, which resulted in attenuated ventricular remodeling and restoration of heart function in rats with myocardial infarction. Our findings might represent a novel therapeutic strategy for heart failure.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21958793     DOI: 10.1016/j.athoracsur.2011.05.054

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Structural and Functional Support by Left Atrial Appendage Transplant to the Left Ventricle after a Myocardial Infarction.

Authors:  Jussi V Leinonen; Päivi Leinikka; Miikka Tarkia; Milla Lampinen; Avishag K Emanuelov; Ronen Beeri; Esko Kankuri; Eero Mervaala
Journal:  Int J Mol Sci       Date:  2022-04-22       Impact factor: 6.208

2.  Comparison of human adipose-derived stem cells isolated from subcutaneous, omental, and intrathoracic adipose tissue depots for regenerative applications.

Authors:  Valerio Russo; Claire Yu; Paul Belliveau; Andrew Hamilton; Lauren E Flynn
Journal:  Stem Cells Transl Med       Date:  2013-12-20       Impact factor: 6.940

3.  The effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarction.

Authors:  Anna Marsano; Robert Maidhof; Jianwen Luo; Kana Fujikara; Elisa E Konofagou; Andrea Banfi; Gordana Vunjak-Novakovic
Journal:  Biomaterials       Date:  2012-10-16       Impact factor: 12.479

4.  Extending flaps lifts an infarcted heart toward repair.

Authors:  Gianni Angelini; Massimo Caputo; Paolo Madeddu
Journal:  Mol Ther       Date:  2015-02       Impact factor: 11.454

5.  Cardio-omentopexy requires a cardioprotective innate immune response to promote myocardial angiogenesis in mice.

Authors:  Zhi-Dong Ge; Riley M Boyd; Connor Lantz; Edward B Thorp; Joseph M Forbess
Journal:  JTCVS Open       Date:  2022-02-24

6.  Omentum support for cardiac regeneration in ischaemic cardiomyopathy models: a systematic scoping review.

Authors:  Hogan Wang; Christopher D Roche; Carmine Gentile
Journal:  Eur J Cardiothorac Surg       Date:  2020-12-01       Impact factor: 4.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.